Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer

Carcinogenesis

Volumn 30, Issue 2, 2009, Pages 340-347

  Mancuso, M ^a   Gallo, D ^b   Leonardi, S ^a   Pierdomenico, M ^a   Pasquali, E ^c   De Stefano, L ^b   Rebessi, S ^b   Tanori, M ^a   Scambia, G ^b   Di Majo, V ^a   Covelli, V ^a   Pazzaglia, S ^a   Saran, A ^a  

^a ENEA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; IRRADIATION; KERATINOCYTE; MOUSE; NONHUMAN; OVARIECTOMY; PAPILLOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ANIMALS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; MALE; MICE; NEOPLASMS, RADIATION-INDUCED; OVARIECTOMY; PAPILLOMA; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 60149098270     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn243     Document Type: Article

References (59)

1. Gloster,H.M. et al. (1996) The epidemiology of skin cancer. Dermatol. Surg., 22, 217-226.
2. Ichihashi,M. et al. (2003) UV-induced skin damage. Toxicology 189, 21-39.
3. MacKie,R.M. (2006) Long-term health risk to the skin of ultraviolet radiation. Prog. Biophys. Mol. Biol., 92, 92-96.
4. Ron,E. et al. (1998) Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control, 9, 393-401.
5. Yoshinaga,S. et al. (2005) Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists. Int. J. Cancer, 115, 828-834.
6. Ramachandran,S. et al. (2003) Combined effects of gender, skin type and polymorphic genes on clinical phenotype: Use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Lett., 189, 175-181.
7. Staples,M.P. et al. (2006) Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med. J. Aust., 184, 6-10.
8. Hayes,R.C. et al. (2007) Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J. Cutan. Med. Surg., 11 45-52.
9. Gawkrodger,D.J. (2004) Occupational skin cancers. Occup. Med. (Lond.) 54, 458-463.
10. Schofield,P.E. et al. (2001) Trends in sun protection behaviour among Australian young adults. Aust. N. Z. J. Public Health, 25 62-65.
11. Thieden,E. et al. (2005) Sunscreen use related to UV exposure, age, sex, and occupation based on personal dosimeter readings and sun-exposure behavior diaries. Arch. Dermatol., 141, 967-973.
12. Marks,R. (1995) The epidemiology of non-melanoma skin cancer: Who, why and what can we do about it. J. Dermatol., 22, 853-857.
13. Rubin,A.I. et al. (2005) Basal-cell carcinoma. N. Engl. J. Med. 353, 2262-2269.
14. Dahmane,N. et al. (1997) Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature, 389, 876-881.
15. Kallassy,M. et al. (1997) Patched (ptch)-associated preferential expression of smoothened (smoh) in human basal cell carcinoma of the skin. Cancer Res., 57, 4731-4735.
16. Wicking,C. et al. (1997) Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am. J. Hum. Genet., 60, 21-26.
17. Fan,H. et al. (1997) Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat. Med., 3 788-792.
18. Ruiz i Altaba,A. (1999) Gli proteins and Hedgehog signaling: Development and cancer. Trends Genet., 15, 418-425.
19. Grachtchouk,M. et al. (2000) Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat. Genet., 24, 216-217.
20. Nilsson,M. et al. (2000) Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl Acad. Sci. USA, 97, 3438-3443.
21. Hahn,H. et al. (1998) Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med., 4, 619-622.
22. Aszterbaum,M. et al. (1999) Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat. Med., 5, 1285-1391.
23. Mancuso,M. et al. (2004) Basal cell carcinoma and its development: insights from radiation induced tumors in Ptch1 deficient mice. Cancer Res., 64, 934-941.
24. Mancuso,M. et al. (2006) Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation. Cancer Res. 66, 6606-6614.
25. Pazzaglia,S. et al. (2004) Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background. Cancer Res., 64, 3798-3806.
26. Karagas,M.R. et al. (2006) Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J. Natl Cancer Inst., 98, 389-395.
27. Yuspa,S.H. (1994) The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis - thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res., 54, 1178-1189.
28. Bangrazi,C. et al. (1990) Genetics of chemical carcinogenesis. 1. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogenesis, 11, 1711-1719.
29. Thomas-Ahner,J.M. et al. (2007) Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Res., 67, 3468-3474.
30. Lupulescu,A. (1981) Hormonal regulation of epidermal tumor development. J. Invest. Dermatol., 77, 186-195.
31. Thornton,M.J. (2002) The biological actions of estrogens on skin. Exp. Dermatol., 11, 487-502.
32. Johnson,E. (1958) Quantitative studies of hair growth in the albino rat. II. The effect of sex hormones. J. Endocrinol., 16, 351-359.
33. Oh,H.S. et al. (1996) An estrogen receptor pathway regulates the telogenanagen hair follicle transition and influences epidermal cell proliferation. Proc. Natl Acad. Sci. USA, 93, 12525-12530.
34. Smart,R.C. et al. (1999) Effects of 17-beta-estradiol and ICI 182 780 on hair growth in various strains of mice. J. Investig. Dermatol. Symp. Proc., 4, 285-289.
35. Chanda,S. et al. (2000) 17Beta-estradiol and ICI-182780 regulate the hair follicle cycle in mice through an estrogen receptor-alpha pathway. Am. J. Physiol. Endocrinol. Metab., 278, E202-E210.
36. Ohnemus,U. et al. (2006) The hair follicle as an estrogen target and source. Endocr. Rev., 27, 677-706.
37. Thornton,M.J. et al. (2003) Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp. Dermatol. 12, 181-190.
38. Ohnemus,U. et al. (2005) Hair cycle control by estrogens: Catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling. Endocrinology, 146, 1214-1225.
39. Saran,A. et al. (1999) Skin tumorigenesis by initiators and promoters of different chemical structures in lines of mice selectively bred for resistance (Car-r) or susceptibility (Car-s) to two-stage skin carcinogenesis. Int. J. Cancer, 83, 335-340.
40. Miller,S.J. et al. (1993) Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: Possible involvement of hair follicle stem cells. J. Invest. Dermatol., 101, 591-594.
41. Müller-Röver,S. et al. (2001) A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J. Invest. Dermatol., 117, 3-15.
42. Zwijsen,R.M. et al. (1997) CDK-independent activation of estrogen receptor by cyclin D1. Cell, 88, 405-415.
43. Lamb,J. et al. (2000) Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell. Biol., 20, 8667-8675.
44. Hecht,J.L. et al. (2006) Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol., 24, 4783-4791.
45. Russo,J. et al. (2006) The role of estrogen in the initiation of breast cancer. J. Steroid Biochem. Mol. Biol., 102, 89-96.
46. International Agency for Research on Cancer. (1999) Hormonal contraception and post-menopausal hormonal therapy. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Vol. 72 IARC, Lyon, France.
47. Weyant,M.J. et al. (2001) Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res., 61, 2547-2551.
48. Grodstein,F. et al. (1998) Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann. Intern. Med., 128, 705-712.
49. Gruber,C.J. et al. (2002) Production and actions of estrogens. N. Engl. J. Med., 346, 340-352. Review.
50. Zouboulis,C.C. et al. (2007) Sexual hormones in human skin. Horm. Metab. Res., 39, 85-95.
51. Nebert,D.W. et al. (1970) Effect of 17-beta-estradiol and testosterone on aryl hydrocarbon hydroxylase activity in mouse tissues in vivo and in cell culture. Int. J. Cancer, 6, 470-480.
52. Perin,F. et al. (1994) Comparison of 7,12-dimethylbenz(a anthracene-DNA adduction in the epidermis of two lines of mice selected for resistance (CAR-R) or susceptibility (CAR-S) to skin carcinogenesis. Cancer Res., 54, 4635-4640.
53. Barton,M.C. et al. (1988) Transient administration of estradiol-17 beta establishes an autoregulatory loop permanently inducing estrogen receptor mRNA. Proc. Natl Acad. Sci. USA, 85, 7119-7123.
54. Isaksson,E. et al. (2002) Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast, 11, 295-300.
55. Gallo,D. et al. (2005) Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: Effects on bone, uterus, and lipid profile. Menopause, 12, 589-600.
56. Liu,M.M. et al. (2002) Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem., 277, 24353-24360.
57. Petre-Draviam,C.E. et al. (2005) A central domain of cyclin D1 mediates nuclear receptor corepressor activity. Oncogene, 24 431-444.
58. Aaltonen,K. et al. (2008) Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer. Breast Cancer Res. Treat., Feb 1. (epub ahead of print).
59. Kanda,N. et al. (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J. Dermatol. Sci., 38, 1-7.